Biotron Limited is engaged in the research, development, and commercialisation of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1, and a promising preclinical program for HBV. In addition, Biotron has several earlier stage...See more
Headquarter Australia |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |